Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma.
Saved in:
| Title: | Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma. |
|---|---|
| Authors: | Mercieca-Bebber, R.1 (AUTHOR), Barnes, E. H.1 (AUTHOR), Wilson, K.1 (AUTHOR), Samoon, Z.1 (AUTHOR), Walpole, E.2,3 (AUTHOR), Mai, T.4 (AUTHOR), Ackland, S.5 (AUTHOR), Burge, M.4,6 (AUTHOR), Dickie, G.6 (AUTHOR), Watson, D.7 (AUTHOR), Leung, J.8 (AUTHOR), Wang, T.9 (AUTHOR), Bohmer, R.10 (AUTHOR), Cameron, D.11 (AUTHOR), Simes, J.1 (AUTHOR), Gebski, V.1 (AUTHOR), Smithers, M.4,12 (AUTHOR), Thomas, J.13 (AUTHOR), Zalcberg, J.14 (AUTHOR), Barbour, A. P.2,4 (AUTHOR) a.barbour@uq.edu.au |
| Source: | BMC Cancer. 3/15/2022, Vol. 22 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-022-09270-4 |
